We are live on ! Find out more
BVXVW

BiondVax Pharmaceuticals Ltd.
BVXVW

Delisted

BVXVW was delisted on the 13th of May, 2020.

Back to rankings

3 hedge funds and large institutions have $32K invested in BiondVax Pharmaceuticals Ltd. in 2019 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% less funds holding

Funds holding: 4 → 3 (-1)

30% less capital invested

Capital invested by funds: $46K → $32K (-$14K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Mariner
Mariner
Kansas
-$5K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$224
Name Holding Trade Value Shares
Change 		Change in
Stake
CH
1
CVI Holdings
Delaware
$25K – – –
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$7K -$224 -400 -2%
Mariner
3
Mariner
Kansas
– -$5K -12,000 Closed

BVXVW Hedge Fund Activity: Q1 2019 in Review

3 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in BiondVax Pharmaceuticals Ltd. (BVXVW) for Q1 2019, worth a combined $32K — down 30% from $46K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of BVXVW and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.

The largest seller was Mariner, exiting entirely with an estimated $5K sold.

  • 3 institutional investors held BiondVax Pharmaceuticals Ltd. (BVXVW) as of Q1 2019, down from 4 in Q4 2018.
  • Funds reported $32K of BiondVax Pharmaceuticals Ltd. stock for Q1 2019, down 30% quarter-over-quarter.
  • 0 funds opened new BiondVax Pharmaceuticals Ltd. positions in Q1 2019 and 1 closed out, a net change of -1 holder.
  • The largest BiondVax Pharmaceuticals Ltd. seller in Q1 2019 was Mariner, an estimated $5K sold.

Based on aggregated 13F filings for Q1 2019.